Related references
Note: Only part of the references are listed.Revisiting FDA Approval of Aducanumab
G. Caleb Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Fulfilling the Mandate of the US Food and Drug Administration's Accelerated Approval Pathway The Need for Reforms
Bishal Gyawali et al.
JAMA INTERNAL MEDICINE (2021)
FDA Approval and Regulation of Pharmaceuticals, 1983-2018
Jonathan J. Darrow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval
Bishal Gyawali et al.
JAMA INTERNAL MEDICINE (2019)
Accelerated Approval and Expensive Drugs - A Challenging Combination
Walid F. Gellad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Surrogate Outcomes in Clinical Trials A Cautionary Tale
Staffan Svensson et al.
JAMA INTERNAL MEDICINE (2013)
Reputation and Precedent in the Bevacizumab Decision
Daniel Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)